Alberta Investment Management Corp (AIMCo)’s Collegium Pharmaceutical COLL Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,300	Closed	-$1.2M	–	645
2025 Q1	$1.2M	Hold	40,300	–	–	0.01%	553
2024 Q4	$1.15M	Hold	40,300	–	–	0.01%	580
2024 Q3	$1.56M	Hold	40,300	–	–	0.01%	479
2024 Q2	$1.3M	Hold	40,300	–	–	0.01%	465
2024 Q1	$1.56M	Buy	+40,300	New	+$1.41M	0.02%	504
2019 Q4	–	Sell	-58,300	Closed	-$669K	–	937
2019 Q3	$669K	Buy	58,300 +18,600	+47%	+$212K	0.01%	716
2019 Q2	$522K	Sell	39,700 -8,700	-18%	-$116K	﹤0.01%	759
2019 Q1	$733K	Buy	+48,400	New	+$775K	0.01%	689

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s COLL Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 40,300 shares — an estimated $1.2M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in COLL in Q1 2019 and held it in 8 quarters. The position peaked at $1.56M in Q1 2024. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

Alberta Investment Management Corp (AIMCo) reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 40,300 Collegium Pharmaceutical shares in Q2 2025, an estimated $1.2M.
Alberta Investment Management Corp (AIMCo) first reported a position in Collegium Pharmaceutical in Q1 2019 and held it in 8 quarters.
Alberta Investment Management Corp (AIMCo)'s Collegium Pharmaceutical position peaked at $1.56M in Q1 2024.
223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.